MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mineralys Therapeutics (MLYS) Ownership - Who owns Mineralys Therapeutics?

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more

Profile

Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
76
Web
https://mineralystx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.85B
P/E Ratio
-4.98
Total Cash
661.41M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash/Share
7.48
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Mineralys Therapeutics? MLYS symbol Ownership - Tickeron.com